Cereblon Control of Zebrafish Brain Size by Regulation of Neural Stem Cell Proliferation

Summary Thalidomide is a teratogen that causes multiple malformations in the developing baby through its interaction with cereblon (CRBN), a substrate receptor subunit of the CRL4 E3 ubiquitin ligase complex. CRBN was originally reported as a gene associated with autosomal recessive non-syndromic mild mental retardation. However, the function of CRBN during brain development remains largely unknown. Here we demonstrate that CRBN promotes brain development by facilitating the proliferation of neural stem cells (NSCs). Knockdown of CRBN in zebrafish embryos impaired brain development and led to small brains, as did treatment with thalidomide. By contrast, overexpression of CRBN resulted in enlarged brains, leading to the expansion of NSC regions and increased cell proliferation in the early brain field and an expanded expression of brain region-specific genes and neural and glial marker genes. These results demonstrate that CRBN functions in the determination of brain size by regulating the proliferation of NSCs during development.
Graphical Abstract
Highlights • CRBN is a determinant of head and brain size during zebrafish development • Thalidomide causes a reduction in head and brain size by binding to CRBN • CRBN prevents apoptosis and promotes NSC proliferation during brain development • crbn overexpression results in a concomitant increase in neurons and glial cells
Cellular Neuroscience; Developmental Neuroscience; Molecular Neuroscience